Biocon stock opened with a loss of 9.36% at Rs 181 against the previous close of Rs 199.70 on BSE. The stock touched an intraday low of Rs 347.9, falling 11.73% on BSE.
She said the deal will enable BBL to attain a robust commercial engine in the developed markets of U.S. & Europe and will fast-track the company s journey of building a strong global brand. Biocon Biologics to Acquire Viatris Biosimilars Assets for Up to USD 3.335 Billion in Stock and Cash.